Sibutramine, a serotonin uptake inhibitor, increases dopamine concentrations in rat striatal and hypothalamic extracellular fluid

This publication has 27 references indexed in Scilit:

• A Double‐Blind Randomized Placebo‐Controlled Trial of Sibutramine
  Obesity Research, 1996
• D1 receptor binding in rat striatum: modification by various D1 and D2 antagonists, but not by sibutramine hydrochloride, antidepressants or treatments which enhance central dopaminergic function
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1995
• [3H]Paroxetine binding in rat frontal cortex strongly correlates with [3H]5-HT uptake: Effect of administration of various antidepressant treatments
  Neuropharmacology, 1993
• A comparison of the effects of sibutramine hydrochloride, bupropion and methamphetamine on dopaminergic function: evidence that dopamine is not a pharmacological target for sibutramine
  Psychopharmacology, 1992
• A comparison of various antidepressant drugs demonstrates rapid desensitisation of α2-adrenoceptors exclusively by sibutramine hydrochloride
  Psychopharmacology, 1992
• Effects of antidepressant drugs and electroconvulsive shock on pre- and postsynaptic α2-adrenoceptor function in the brain: rapid down-regulation by sibutramine hydrochloride
  Psychopharmacology, 1991
• A new and highly sensitive method for measuring 3-methoxytyramine using HPLC with electrochemical detection. Studies with drugs which alter dopamine metabolism in the brain
  Neuropharmacology, 1990
• Antidepressant Treatments, Including Sibutramine Hydrochloride and Electroconvulsive Shock, Decrease β₁ but Not β₂‐Adrenoceptors in Rat Cortex
  Journal of Neurochemistry, 1989
• The pharmacology of sibutramine hydrochloride (BTS 54 524), a new antidepressant which induces rapid noradrenergic down-regulation
  Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1988
• A rapid method for preparing synaptosomes: Comparison, with alternative procedures
  Brain Research, 1981